Why animal testing still drives drug approvals in India, and what it costs pharma?
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK and Japan. It highlights areas where Indian regulators continue to require animal studies despite the availability of established human data and validated non-animal testing methods.
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK and Japan. It highlights areas where Indian regulators continue to require animal studies despite the availability of established human data and validated non-animal testing methods.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
